C4 Therapeutics

(NASDAQ) CCCC

Current Price$2.94

Market Cap$289.81M

Since IPO (2020)-88%

5 Year-91%

1 Year+108%

1 Month+3%

C4 Therapeutics Financials at a Glance

Market Cap

$289.81M

Revenue (TTM)

$35.95M

Net Income (TTM)

$104.99M

EPS (TTM)

$-1.36

P/E Ratio

-2.19

Dividend

$0.00

Beta (Volatility)

1.98 (High)

Dividend

$0.00

Beta (Volatility)

1.98 (High)

Price

$2.94

Volume

1,315,927

Open

$3.00

Price

$2.94

Volume

1,315,927

Open

$3.00

Previous Close

$2.93

Daily Range

$2.90 - $3.01

52-Week Range

$1.21 - $3.82

Dividend

$0.00

Beta (Volatility)

1.98 (High)

Price

$2.94

Volume

1,315,927

Open

$3.00

Previous Close

$2.93

Daily Range

$2.90 - $3.01

52-Week Range

$1.21 - $3.82

CCCC News

Two people participating in a telehealth session

Why C4 Therapeutics Stock Crushed the Market on Monday

Eric VolkmanSep 15, 2025

CCCC Revenue Drops 46%

Motley Fool Markets TeamAug 7, 2025

CCCC: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About C4 Therapeutics

Industry

Biotechnology

Sector

Health Care

Employees

104

CEO

Andrew J. Hirsch, MBA

Website

www.c4therapeutics.com

Headquarters

Watertown, MA 02472, US

CCCC Financials

Key Financial Metrics (TTM)

Gross Margin

95%

Operating Margin

-3%

Net Income Margin

-3%

Return on Equity

-44%

Return on Capital

-35%

Return on Assets

-29%

Earnings Yield

-45.66%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$289.81M

Shares Outstanding

97.58M

Volume

1.32M

Avg. Volume

2.73M

Financials (TTM)

Gross Profit

$27.97M

Operating Income

$104.49M

EBITDA

$102.91M

Operating Cash Flow

$98.69M

Capital Expenditure

$607.00K

Free Cash Flow

$99.30M

Cash & ST Invst.

$248.54M

Total Debt

$59.98M

C4 Therapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$11.02M

+112.8%

Gross Profit

$9.21M

+170.0%

Gross Margin

83.61%

N/A

Market Cap

$289.81M

N/A

Market Cap/Employee

$2.63M

N/A

Employees

110

N/A

Net Income

$20.49M

+40.7%

EBITDA

$19.94M

+39.0%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$188.56M

+5.3%

Accounts Receivable

$2.40M

-22.6%

Inventory

$0.00

N/A

Long Term Debt

$53.62M

-10.6%

Short Term Debt

$6.37M

+10.3%

Return on Assets

-29.24%

N/A

Return on Invested Capital

-35.34%

N/A

Free Cash Flow

$22.16M

-23.6%

Operating Cash Flow

$22.14M

-23.5%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

CDXSCodexis, Inc.

CDXSCodexis, Inc.$2.66-3.27%

MISTMilestone Pharmaceuticals Inc.

MISTMilestone Pharmaceuticals Inc.$1.97+4.79%

OABIOmniAb, Inc.

OABIOmniAb, Inc.$1.43+2.14%

MOLNMolecular Partners AG

MOLNMolecular Partners AG$4.29+0.83%

IMDXInsight Molecular Diagnostics Inc.

IMDXInsight Molecular Diagnostics Inc.$5.03+9.83%

PEPGPepGen Inc.

PEPGPepGen Inc.$1.84-4.40%

SGMOSangamo Therapeutics, Inc.

SGMOSangamo Therapeutics, Inc.$0.18+31.56%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$13.19-0.02%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.14-0.12%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.58+0.05%

CPNGCoupang

CPNGCoupang$17.89-0.14%

SNAPSnap

SNAPSnap$6.11+0.33%

CTRACoterra Energy

CTRACoterra Energy$32.56-0.09%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$71.57+0.06%

Questions About CCCC

What is the current price of C4 Therapeutics?

C4 Therapeutics is trading at $2.93 per share.

What is the 52-week range for C4 Therapeutics?

Over the past 52 weeks, C4 Therapeutics has traded between $1.21 and $3.82.

How much debt does C4 Therapeutics have?

As of the most recent reporting period, C4 Therapeutics reported total debt of $59.98M.

How much cash does C4 Therapeutics have on hand?

C4 Therapeutics reported $74.60M in cash and cash equivalents in its most recent financial results.

What is C4 Therapeutics’s dividend yield?

C4 Therapeutics does not currently have a dividend yield.

C4 Therapeutics

C4 Therapeutics Financials at a Glance

CCCC News

Why C4 Therapeutics Stock Crushed the Market on Monday

CCCC Revenue Drops 46%

CCCC: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About C4 Therapeutics

CCCC Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

C4 Therapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About CCCC

What is the current price of C4 Therapeutics?

What is the 52-week range for C4 Therapeutics?

How much debt does C4 Therapeutics have?

How much cash does C4 Therapeutics have on hand?

What is C4 Therapeutics’s dividend yield?

Premium Investing Services